1. Home
  2. MFM vs ANIK Comparison

MFM vs ANIK Comparison

Compare MFM & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Municipal Income Trust

MFM

MFS Municipal Income Trust

HOLD

Current Price

$5.53

Market Cap

228.6M

Sector

Finance

ML Signal

HOLD

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.58

Market Cap

197.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MFM
ANIK
Founded
1986
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
228.6M
197.6M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
MFM
ANIK
Price
$5.53
$14.58
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
123.1K
112.5K
Earning Date
01-01-0001
04-29-2026
Dividend Yield
4.08%
N/A
EPS Growth
N/A
80.16
EPS
0.03
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
$184.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.03
$7.90
52 Week High
$5.67
$16.24

Technical Indicators

Market Signals
Indicator
MFM
ANIK
Relative Strength Index (RSI) 64.30 48.50
Support Level $5.51 $13.81
Resistance Level $5.58 $15.74
Average True Range (ATR) 0.05 0.93
MACD 0.02 -0.05
Stochastic Oscillator 83.33 63.55

Price Performance

Historical Comparison
MFM
ANIK

About MFM MFS Municipal Income Trust

MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: